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Abstract
Background—Among physicians who perform endoscopic retrograde
cholangiopancreatography (ERCP), the relationship between procedure volume and outcome is
unknown.
Objective—Quantify the ERCP volume-outcome relationship by measuring provider-specific
failure rates, hospitalization rates and other quality measures.
Research Design—Retrospective Cohort
Subjects—16,968 ERCPs performed by 130 physicians between 2001-2011, identified in the
Indiana Network for Patient Care (INPC)
Measures—Physicians were classified by their average annual INPC volume and stratified into
low (<25/year) and high (≥25/year). Outcomes included failed procedures, defined as repeat
ERCP, percutaneous transhepatic cholangiography or surgical exploration of the bile duct ≤ 7 days
after the index procedure, hospitalization rates, and 30-day mortality.
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Results—Among 15,514 index ERCPs, there were 1,163 (7.5%) failures; the failure rate was
higher among low (9.5%) compared to high volume (5.7%) providers (p<0.001). A second ERCP
within 7 days (a subgroup of failure rate) occurred more frequently when the original ERCP was
performed by a low (4.1%) versus a high volume physician (2.3%, p=0.013). Patients were more
frequently hospitalized within 24 hours when the ERCP was performed by a low (28.3%) vs. high
volume physician (14.8%, p=0.002). Mortality within 30 days was similar (low – 1.9%, high –
1.9%). Among low volume physicians and after adjusting, the odds of having a failed procedure
decreased 3.3% (95% CI 1.6-5.0%, p<0.001) with each additional ERCP performed per year.
Conclusions—Lower provider volume is associated with higher failure rate for ERCP, and
greater need for post-procedure hospitalization.
Keywords
ERCP quality; outcomes; gastroenterology
Introduction
There is an increasing emphasis on improving quality of care by implementing minimum
volume standards for high-risk procedures. An inverse relationship between provider or
facility volume and outcomes has been established for a variety of procedures including
upper endoscopy1, colonoscopy2-4, hepato-biliary-pancreatic surgery5, 6 and inpatient
management of chronic diseases such as congestive heart failure.7 The study of volume-
outcome relationships has led to minimum volume standards in coronary artery bypass graft
surgery.8, 9 Intuitively, all high-risk procedures should require a minimum volume standard;
however, there are considerable knowledge gaps in certain fields, including endoscopic
retrograde cholangiopancreatography (ERCP).
ERCP is one of the most technically complex and high risk endoscopic procedures, the
volume-outcome relationship for which is incompletely understood.10-16 Despite a paucity
of data on the topic, experts generally agree that lower volume (endoscopist and facility) is
associated with higher failure rates.17 Therefore, quantifying the volume-outcome
relationship for potential targeting of system redesign is increasingly important as U.S.
health care policy transitions to a value-based reimbursement or pay-for-performance
system.18 We sought to quantify the relationship between endoscopist volume and failure
rates using a regional health information exchange. Our primary aim is to compare failure
rates between providers of varying ERCP volume while adjusting for potential confounders.
Secondary aims include a presentation of other quality measures, including the rate of
diagnostic-only ERCP, post-procedure hospitalization, and 30-day mortality.
Methods
Study Design and Population
We conducted a retrospective cohort study of ERCP procedures identified using insurance
claims data derived from the Indiana Network for Patient Care (INPC), a nationally
recognized regional health information exchange.19 Claims data are not restricted to INPC
hospitals and include public (Indiana Medicaid) and commercial insurers. Based on
membership in Indiana Medicaid and commercial insurance providers included in this
cohort, we estimate that 2.28 million Indiana residents (35% of the state population) are
represented. Besides insurance claims data, the INPC includes electronic health records data
for many facilities ranging from large academic referral centers to community hospitals.
Payer claims for ERCP procedures between January, 2001 and December, 2011 were
identified using Current Procedural Terminology, edition 4 (CPT-4) codes and the
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International Classification of Diseases, 9th edition (ICD-9), with each ERCP classified as a
distinct event. We validated coding accuracy for the index ERCP and capture of the second
ERCP by manual record review of 150 medical records. The study was approved by the
Indiana University Office of Research Administration and by the Indiana Office of Medicaid
Policy and Planning.
Provider Classification
Endoscopists included gastroenterologists and general surgeons who were classified by their
average annual ERCP volume. The list of providers was manually reviewed by three
physicians to verify that each provider performed ERCP. To confirm balanced data capture
across all providers, we present the average annual number of patient encounters (i.e., all
office visits and endoscopic procedures) and number of individual patients having at least
one encounter with the provider. Additional data included patient demographics, inpatient or
outpatient status at the time of ERCP, and procedure indication (defined using ICD-9 codes).
Outcome Measures
The primary outcome was the post-ERCP failure rate, defined as the composite frequency of
the following interventions within 7 days of the index ERCP: having a second (i.e., repeat)
ERCP, percutaneous, transhepatic cholangiogram (PTC), or surgery with exploration of the
biliary tree (excluding cholecystectomy alone). While one or more of these events does not
necessarily equate with a negative outcome, the authors agreed on this composite definition
a priori since the frequency of any or all of these events would be negligible if the index
ERCP is successful from a diagnostic and therapeutic perspective. The proportion of ERCPs
having each of these events is presented individually and as a composite frequency. To
avoid double-counting, an index ERCP was defined as an ERCP with no other ERCPs
performed within the preceding 30 days. Other than failure rates, additional quality
measures included the frequency of purely diagnostic ERCP, defined as an ERCP solely
associated with CPT-4 code 43260; post-procedure hospitalization; and all-cause 30-day
mortality. We present the frequency and outcomes specific to diagnostic-only ERCP since
improvements in less invasive pancreatobiliary imaging such as endoscopic ultrasound and
magnetic resonance cholangiopancreatography have nearly eliminated the need for
diagnostic-only ERCP. For example, these less invasive imaging tests are preferred to ERCP
for patients with a low- or moderate suspicion for choledocholithiasis; if a common bile duct
stone is not visualized, ERCP and its inherent risks can be avoided.20
Procedure classification
Each ERCP may have more than one associated indication (e.g., gallstone disease +
cholangitis). Since an ERCP performed for bile duct diagnosis and therapy is generally
considered less complex and has a lower risk profile, indications are grouped into biliary and
“other” categories when possible.21 “Biliary indications” were restricted to ICD-9 codes
specific to bile duct pathology: gallstones, bile duct injury or obstruction, cholangitis, and
pancreatobiliary malignancy. All other indications, such as acute and chronic pancreatitis,
were classified as “other” since the procedure may have been performed for bile duct
pathology, pancreatic duct pathology, or both. A table of procedure indications with
associated ICD-9 codes is available (see Table, Supplemental Digital Content 1, which lists
all relevant ICD-9 codes).
Statistical Analysis
The nature of the volume-outcome association was investigated by fitting a smooth curve on
the empirical Bayes estimates of the failure rate using the nonparametric local regression
(LOESS) smoothing technique, where the smoothing parameter was selected by the
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corrected Akaike Information Criterion.22 The empirical Bayes estimates of the failure rates
were estimated based on the logistic regression model with provider-specific random effects
where provider volume was modeled as a continuous variable. Providers were then
classified by their INPC annual ERCP volume into two relative volume categories, based on
the smooth curve that describes the association between provider volume and failure
outcome. We present patient, provider and ERCP characteristics along with pre-defined
outcomes using descriptive statistics. Continuous variables are summarized using mean and
standard deviation if the distribution is roughly symmetric and using median and the 25th
and 75th percentiles otherwise. Categorical variables are described using frequency and
proportion. Comparison of these characteristics between provider groups is performed using
t-tests for provider characteristics and using mixed models with provider-specific random
effects for patient and ERCP characteristics/outcomes. Mixed modeling accounts for intra-
provider correlation and stabilizes the estimates of provider effects, especially for providers
with a small number of ERCPs.
To account for differences in patient characteristics (age, sex, race, inpatient status at the
time of ERCP, co-morbidity index), provider characteristics (years since primary board
certification and annual volume), and ERCP indication that might have contributed to the
observed differences in failure rates across provider groups, these factors were included as
covariates in a multivariable model for predicting failure. The multivariable logistic
regression model with provider-specific random effects was used to determine the
association between provider volume and procedure failure while controlling for the effects
of patient- and provider-level covariates. Results are presented using odds ratios (OR), the
corresponding 95% confidence intervals (CI), and p values. For each volume strata, the OR
represents the odds of procedure failure for every additional ERCP performed per year.
Results
Distribution of ERCP services in Indiana
During the 11-year study period we identified 16,968 ERCPs performed by 130 providers.
Of these, 15,514 met criteria for an “index ERCP” while 1,454 (8.6%) had a prior ERCP
performed within 30 days. We validated 96% of index ERCPs and 97% of second ERCPs
performed within 7 days of the first ERCP. Based on the piecewise linear relationship of
relative annual volumes and associated failure rates revealed by the LOESS smooth curve, a
cut-off of 25 ERCPs/year was used to dichotomize providers into low (<25/year) and high
(≥25/year) (figure 1A-B). There was no difference in the annual number of distinct patient
encounters (combination of ERCP and non-ERCP procedures and clinic visits), a surrogate
marker of provider-specific clinical activity, captured in the INPC between low and high
volume groups (p=0.762), suggesting balanced data capture across these groups (table 1).
The majority of providers in both volume groups were gastroenterologists and board-
certified. Provider experience, defined as number of years since primary board certification
as of 2011, was similar in both groups. The geographic distribution of these providers is
illustrated (see Figure, Supplemental Digital Content 2, a map of Indiana illustrating the
distribution of ERCP providers across the state.
Patient and Procedure Characteristics
Patients undergoing ERCP by a low volume provider were more likely to be male (p<0.001)
but similar in terms of age, inpatient status, and baseline comorbidity as defined using the
Charlson co-morbidity index23 (table 1). While inpatient status at the time of ERCP was
similar, patients undergoing ERCP by a low volume provider were more likely to have been
admitted one day prior to the procedure (p=0.001) (table 1).
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Low volume providers more frequently performed ERCPs for a biliary indication (70.2%,
vs. 60.3% among high volume providers), but this did not reach statistical significance
(p=0.224) (table 2). However, the proportion of ERCPs performed for acute cholangitis
(which typically requires ERCP within 24 hours of presentation) was small in both groups
(low – 2.0%, high – 3.0%; p=0.082). High volume providers performed ERCP for bile duct
injury, another biliary indication often requiring intervention within 24 hours, more often
(0.4%) than the low volume group (0.2%, p=0.216). ERCPs having other indications - those
not definitively specific to the biliary tree - were more frequently performed by high volume
providers (72.5% vs. 59.7% among low volume; p=0.015). Chronic pancreatitis (p<0.001),
sphincter of Oddi dysfunction (p=0.006), and other pancreatic pathology (p<0.001) were
substantially more common indications for ERCPs performed by high volume physicians.
Specific indications for ERCP were not associated with greater odds of having a failed
procedure among high volume physicians (table 2); in this subgroup, increasing physician
volume led to a clinically small but statistically significantly higher chance of failure for
ERCPs performed for bile duct obstruction (OR 1.007, p=0.040), while no other indication
was sensitive to changes in physician volume. However, among low volume physicians,
increasing annual volume was associated with significantly lower odds of a failed ERCP
when performed for gallstone disease (OR 0.967, p=0.004), other bile duct/liver pathology
(0.963, p=0.002), bile duct obstruction (OR 0.966, p=0.014), abdominal symptoms (0.956,
p<0.001), or abnormal laboratory parameters (0.956, p=0.001).
Failure rates and other quality measures
The post-ERCP failure rate, defined as a patient requiring a second ERCP, PTC or surgical
exploration of the bile duct ≤ 7 days after the index ERCP, was significantly higher among
low volume (9.5%) compared to high volume (5.7%, p<0.001) providers (table 3). The
composite rate of early repeat ERCP, PTC, and surgery with bile duct exploration (figure
1A-B) illustrates the piecewise linear volume-outcome relationship. Similarly, the incidence
of early (≤ 7 days) repeat ERCP (a subgroup of the definition of procedure failure) was
inversely proportional to provider annual volume: low – 4.1%, high – 2.3% (p=0.013). The
frequency of diagnostic-only ERCP was significantly higher among low volume (15.8%)
compared to high volume providers (7.8%, p=0.016).
Among patients who underwent the procedure as an outpatient, the incidence of immediate
hospitalization (defined as hospitalization within 24 hours of the procedure) was
significantly higher among low (28.3%) as compared to high volume providers (14.8%,
p=0.002). Among patients hospitalized immediately after the ERCP, the length of
hospitalization was similar between groups (p=0.899). Similarly, the rates of hospitalization
within 30 days of the index ERCP were significantly lower among the highest volume
physicians (p=0.023). However, average length of stay was significantly longer for patients
admitted within 30 days of ERCP by a high volume provider (p=0.001), suggesting higher
baseline morbidity among the subgroup requiring hospitalization. Mortality rates within 30
days of the index ERCP were similar between groups (p=0.455).
Factors associated with greater odds of procedure failure included male sex (OR 1.257, 95%
CI: 1.097, 1.440), inpatient status at the time of the procedure (OR 1.521 [1.315, 1.759]),
and having a Charlson score ≥ 1 (OR 1.398 [1.058, 1.848]). ERCP indications associated
with greater odds of failure included gallstone disease (p=0.028) and bile duct obstruction
(p<0.001), whereas acute pancreatitis (p=0.008) and chronic pancreatitis (p=0.001) were
associated with a lower failure rate. Physician experience, defined as years since initial
board certification, was not significantly associated with a lower rate of failure (p=0.441).
Among low volume physicians, the adjusted odds of a failed procedure were significantly
lower with each unit increase in procedure volume (OR 0.967 [0.950, 0.984], p<0.001).
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Stated alternatively, for each additional ERCP performed per year by a low volume
provider, the odds of failure decreased by 3.3% (95% CI 1.6-5.0%). Differences in
procedure volume among high volume providers did not impact odds of failure (p=0.997).
Conclusions
Over the past two decades, there has been a slow increase in the number of patients referred
for ERCP to an academic medical center after having a failed procedure at a lower-volume
facility.24 Therefore, we emphasize failure rates, frequency of diagnostic-only ERCP, and
need for hospitalization as key quality measures in an effort to define the endoscopist
volume-outcome relationship. Previous studies evaluating this relationship are
conflicting.11-14, 25 These studies are limited by voluntary reporting of outcomes,14
emphasis on procedural complications that are highly dependent on the pre-procedure
indication, and sampling frames with small numbers of physicians or facilities. Varadarajulu
and colleagues previously reported higher failure rates and longer hospitalizations for
ERCPs performed at lower volume facilities but did not consider individual provider
volume.12 In their study, failure was defined as the need for PTC or bile duct exploration but
did not include the rate of early repeat ERCP, an important measure of incomplete therapy.
In addition, Varadarajulu, et al. restricted their analysis to select ICD-9 codes (cholelithiasis,
other disorders of the biliary tract, and diseases of the pancreas) and did not include purely
diagnostic ERCPs. In our cohort, failure rates were higher among purely diagnostic ERCPs,
presumably because the majority of diagnostic ERCPs represent cases in which one or both
ducts can be opacified but the physician is unable to proceed with necessary therapy (e.g.,
sphincterotomy, stone removal, stent placement) for technical reasons. The alternative
explanation is that the procedure was performed for diagnosis alone. In either case, a
diagnostic-only ERCP represents lower quality care. Therefore, our observation that rates of
purely diagnostic ERCP are higher among low volume providers is another important
measure of quality, since the need for diagnostic ERCP has been obviated by alternative,
less invasive imaging modalities. The study by Varadarajulu, et al. observed a facility
volume-outcome relationship that is congruent with our results at the provider level. It is
unlikely that correcting for facility volume in our analysis would eliminate the observed
provider outcome relationship since provider and facility volume are often closely linked:
the majority of low volume providers perform ERCP typically at low volume facilities.
There are several compelling reasons that the “value” (i.e., outcome for each dollar spent18)
of ERCP services in the U.S. is low. First, its utilization has plateaued over the last decade
since it has been largely replaced as a purely diagnostic tool by less invasive modalities such
as endoscopic ultrasound and magnetic resonance cholangiopancreatography.26, 27 As a
result, there are comparatively fewer procedures to disperse among ERCP providers who
need to develop and maintain their technical expertise. Second, the majority (95%) of
ERCPs performed in the United States are completed in lower volume (<200 per year)
facilities.12 Low volume units are less efficient than high volume units, which can achieve a
lower average cost. Third, ERCP is performed less frequently than other endoscopic
procedures, and is frequently required in an urgent setting (e.g., symptomatic
choledocholithiasis or obstructive jaundice). Large (> 5 providers) specialty practices are
reluctant to centralize ERCP services in part due to the implications for night and weekend
coverage.28 However, there is almost invariably an opportunity to delay the procedure for a
limited time since indications for emergent (< 24 hours after presentation) ERCP such as
cholangitis (2.6% in our cohort) and some cases of bile duct injury (0.3% in our cohort) are
uncommon. Since the current U.S. healthcare delivery system has traditionally incentivized
quantity over quality, hospitals presumably choose to offer ERCP in order to benefit from
“downstream revenue:” utilization of cross-sectional imaging, surgery, and hospitalization.
However, in the era of healthcare reform and patient-reported outcomes, a more conscious
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effort to balance cost and quality will continue to evolve. Fourth, ERCP is one of the most
technically difficult endoscopic procedures with a high risk profile, and most
gastroenterologists who perform it have limited training due to the aforementioned factors.28
Finally, as shown in our cohort, the majority (116 of 130, 89%) of physicians performing
ERCP do very little of it.
Particular strengths of our study are the inclusion of both commercial and public payers;
given the indications for ERCP such as choledocholithiasis, this population is more
generalizable than a Medicare population of individuals > age 65. Another advantage is the
large sample size across the diverse demography of Indiana, derived from a nationally
recognized health information exchange. Our inclusion of all reported indications for ERCP
improves the generalizability of the results and underscores that, despite higher failure and
post-procedure hospitalization rates, low volume providers are more likely to perform ERCP
for indications that typically have lower complexity and complication rates. Therefore, it is
possible that our observed differences are biased against high volume providers. However,
use of ICD-9 codes to define indications does not necessarily distinguish high and low
complexity procedures: a 4mm gallstone that can be easily removed following biliary
sphincterotomy would have the same code as a 20mm stone that requires mechanical or
electrohydraulic lithotripsy. Finally, our definition of failure is specific but has lower
sensitivity since a substantial group of patients may have required a repeat ERCP, PTC or
bile duct exploration after 7 days due to an unsuccessful index procedure (e.g., painless
jaundice, choledocholithiasis without acute symptoms). It is very unlikely that we have
overestimated the failure rate since a second bile duct intervention in ≤ 7 days after ERCP is
almost never clinically indicated if the index procedure is successful; specific cases such as
Mirizzi syndrome may require surgical exploration after a successful ERCP but this is
usually deferred several weeks to allow normalization of cholestatic liver tests. Furthermore,
changing the window for failure to 15 or 30 days did not significantly change the results; a
significant relationship between low volume and higher failure rates persisted (data not
shown).
There are important limitations to consider. First, we did not quantify the interaction
between physician and facility volume since the latter could not be reliably measured.
Second, we did not measure other physician-specific factors that may affect outcomes, such
as annual volume prior to the onset of this study and quality of ERCP training. Consistent
with our analysis, a previous study of 1,335 ERCPs observed lower complication rates from
sphincterotomy among higher volume providers, irrespective of experience, defined as years
since training.29 Third, we do not present rates of ERCP-specific complications such as
pancreatitis, gastrointestinal bleeding, cholangitis and bowel perforation; these are expected
to correlate with procedure indication more than to our definition of failure. However, our
observation that hospitalization rates within 24 hours of the procedure are higher among low
volume providers can be explained either by a tendency among low volume providers to
admit more patients for observation post-procedure or by a higher incidence of post-
procedure complications. In either case, higher post-procedure hospitalization rates suggest
lower quality of care, excess resource utilization, or both, but require confirmation through
more direct study. Finally, while the INPC data is high quality19 it does not capture all
ERCPs performed by each provider. Interestingly, we found similar rates of overall clinical
productivity, defined as total number of clinical encounters per provider, between the high
and low ERCP volume provider groups, which suggests that we are not misclassifying
providers as low volume simply on the basis of missing data. We estimate that the observed
INPC volumes imply overall annual volumes of < 117 ERCPs/year for low volume
providers. However, INPC-specific volumes should not be considered as “thresholds” for
future guidelines/recommendations without more direct study. A low volume cut-off of 117
procedures is consistent with previous studies suggesting lower complication rates among
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physicians performing > 100 ERCPs annually.29 This has important implications for systems
redesign, since we observed similar outcomes for all providers exceeding this threshold.
In conclusion, despite performing ERCP more frequently for indications having greater
technical complexity and risk, higher volume providers have lower failure rates and
hospitalization rates compared to lower volume physicians. The magnitude of this volume-
outcome relationship highlights the importance of developing benchmark reports for ERCP
outcomes that are provider- and facility-specific, as the Gastrointestinal Quality
Improvement Consortium (GIQUiC) developed for colonoscopy.30 The consequences that
ERCP-specific outcome reporting might have upon current patient preferences to receive
care locally and the potential to widen or to narrow disparities in care require further
investigation.31-33 ERCP outcomes may be similar to pancreatectomy, the mortality from
which significantly declined as the surgery was performed in more selective centers.34 In
addition to performance transparency, a recent Institute of Medicine report emphasized the
need to utilize systems engineering tools and process improvement methods to provide the
best care at lower cost.35 Efforts to concentrate ERCP services among fewer, higher volume
providers may help to achieve this goal.
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Figure 1A-B. Composite Failure Rate of ERCP by Provider Volume
Scatterplot depicting composite rates of repeat ERCP, PTC and surgery with bile duct
exploration performed within 7 days of the index ERCP, with dotted vertical line delineating
volume groups (1A). Frequencies are given using Bayes estimates. The failure rate is
inversely proportional to provider annual volume, confirming a volume-outcome
relationship. The size of each bubble is proportional to the number of ERCPs performed.
The x axis reflects annual ERCP volume based on INPC data. Since the logistic regression
model assumes the logit of the outcome as a linear function of the predictors, we show the
logit of the failure rate estimate against physician volume (1B). The solid line is the
nonparametric smoothing curve that best describes the relationship between physician
volume and the logit of the failure rate.
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Table 1
Patient and Provider Characteristics
Variable
Annual volume†
Low High Total P value
Provider characteristics
n=116 Providers n=14 Providers n=130 Providers
Annual ERCP volume (# ERCPs/year), mean (SD) 7.9 (5.1) 60.7 (39.8) 13.6 (21.3)
Total number of distinct patient encounters/year, mean (SD) 817.7 (568.4) 866.0 (514.8) 822.9 (561.2) 0.762
Total number of patients/year, mean (SD) 415.5 (201.5) 443.2 (222.9) 418.5 (203.2) 0.632
Physician specialty, n (%) Gastroenterologist 106 (91.4%) 14 (100%) 120 (92.3%) 0.599
Board Certification 106 (94.6%) 10 (83.3%) 116 (93.6%)
0.173
    Missing, n 4 2 6
Years of board certification, as of 2011, mean (sd) 17.1 (9.0) 18.2 (8.5) 17.2 (9.0)
0.701
    Missing, n 8 1 9
Patient characteristics
n=7,484 ERCPs n=8,030 ERCPs n=15,514 ERCPs
Inpatient status at the time of ERCP, n (%) 3,138 (41.9%) 2,631 (32.8%) 5769 (37.2%) 0.198
        • Admitted one day before ERCP 1,122 (15.0%) 655 (8.2%) 1777 (11.5%) 0.001
        • Admitted 2+ day before ERCP 2,016 (26.9%) 1,976 (24.6%) 3992 (25.7%) 0.879
Patient age, mean (sd) 53.2 (20.3) 50.0 (18.4) 51.5 (19.4)
0.547
    Missing, n 638 766 1404
Male sex, n (%) 1,994 (29.1%) 2,678 (36.9%) 4,672 (33.1%)
<0.001
    Missing, n 639 766 1405
Ethnic group, n (%)
0.240
    White 4,618 (81.5%) 6,016 (85.1%) 10,634 (83.5%)
    African American 644 (11.4%) 727 (10.3%) 1,371 (10.8%)
    Other 406 (7.2%) 326 (4.6%) 732 (5.7%)
    Missing, n 1,816 961 2777
Charlson Co-morbidity Index
0.169    0 7,162 (95.7%) 7,683 (95.7%) 14,845 (95.7%)
    1+ 322 (4.3%) 347 (4.3%) 669 (4.3%)
†Annual volume was defined by the average annual number of ERCPs performed by an individual provider in the INPC. Low annual volume: ≤ 25
ERCPs/year; high annual volume: >25 ERCPs/year.
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Table 2
Effect of physician volume on 7-day failure outcome, stratified by indication for ERCP
Procedure Indication Low (n=116 providers with 7,484
ERCPs)
High (n=14 providers with 8,030 ERCPs) Total (n=130
providers with
15,514 ERCPs)
N (%) Odds Ratio P value N (%) Odds Ratio P value
Biliary Indications 5,254 (70.2%) 4,842 (60.3%) 10,096 (66.4%)
    • Gallstone disease 3,211 (42.9%) 0.967 0.004 1,926 (24.0%) 0.998 0.623 5,137 (33.1%)
    • Other bile duct/liver
pathology
1,312 (17.5%) 0.963 0.002 2,158 (26.9%) 0.999 0.829 3,470 (22.4%)
    • Bile duct obstruction 1,262 (16.9%) 0.966 0.014 1,785 (22.2%) 1.007 0.040 3,047 (19.6%)
    • Cholangitis 152 (2.0%) 244 (3.0%) 396 (2.6%)
    • Bile duct injury 12 (0.2%) 34 (0.4%) 46 (0.3%)
    • Malignancy, Pancreas 118 (1.6%) 148 (1.6%) 266 (1.7%)
    • Malignancy, Bile Duct/
Liver
77 (1.0%) 92 (1.2%) 169 (1.1%)
Other Indications 4,468 (59.7%) 5,819 (72.5%) 10,287 (67.7%)
    • Abdominal symptoms 2,707 (36.2%) 0.956 <0.001 3,069 (38.2%) 0.996 0.182 5,776 (37.2%)
    • Abnormal laboratory
parameters
1,474 (19.7%) 0.956 0.001 1,401 (17.5%) 1.006 0.077 2,875 (18.5%)
    • Acute pancreatitis 735 (9.8%) 0.989 0.610 808 (10.1%) 0.992 0.118 1,543 (10.0%)
    • Chronic pancreatitis 356 (4.8%) 0.972 0.391 1,229 (15.3%) 1.000 0.979 1,585 (10.2%)
    • Malignancy NOS 75 (1.0%) 174 (2.2%) 249 (1.6%)
    • Other pancreatic
pathology
240 (3.2%) 1,232 (15.3%) 1,472 (9.5%)
    • Sphincter of Oddi
dysfunction
173 (2.3%) 1,158 (14.2%) 1,331 (8.6%)
Other (none of the above) 178 (2.4%) 136 (1.7%) 314 (2.0%)
• Each procedure may have more than one indication, so numbers do not add up to 100%.
• Odds ratio represents the odds of having a failed procedure for an increase in annual ERCP volume of n=1 among low and high volume
physicians, respectively. For example, among low volume physicians performing an ERCP for gallstone disease, the odds of having a failed
procedure are 3.3% lower for each increase of one ERCP per year.
• With the exception of bile duct obstruction, the odds of having a failed procedure did not significantly change among high volume providers per
unit increase in ERCP volume.
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Table 3
ERCP Quality Measures
Outcome Low (n=116
providers with 7,484
ERCPs)
High (n=14
providers with 8,030
ERCPs)
Total (n=130
providers with
15,514 ERCPs)
P value*
7-day Failure rate – Total 707 (9.5%) 456 (5.7%) 1163 (7.5%) <0.001
    • Early repeat ERCP 306 (4.1%) 188 (2.3%) 494 (3.2%) 0.013
    • PTC or surgery 442 (5.9%) 283 (3.5%) 725 (4.7%) 0.001
Diagnostic-only ERCP 1,182 (15.8%) 627 (7.8%) 1809 (11.7%) 0.016
    • 7-day repeat ERCP rate 118 (10.0%) 40 (6.4%) 158 (8.7%) 0.091
    • 7-day rate of PTC or surgery 108 (9.1%) 40 (6.4%) 148 (8.2%) 0.096
    • 7-day composite failure rate 209 (17.7%) 77 (12.3%) 286 (15.8%) 0.049
Immediate hospitalization after ERCP†¥ 1,231 (28.3%) 801 (14.8%) 2032 (20.9%) 0.002
    • Length of stay, days (median, 25th and 75th
percentile)
3.0 (2.0, 5.0) 3.0 (2.0, 5.0) 3.0 (2.0, 5.0) 0.899‡
Hospitalization in 30 days after ERCP† 1,811 (41.7%) 1,641 (30.4%) 3452 (35.4%) 0.023
    • Length of stay, days (median, 25th and 75th
percentile)
4.0 (2.0, 7.0) 4.0 (2.0, 10.0) 4.0 (2.0, 7.0) 0.001‡
30-day mortality 140 (1.9%) 154 (1.9%) 294 (1.9%) 0.455
*
P-values are obtained by adjusting the clustering effect of providers using a logistic regression model with random effects.
†
Hospitalization data are limited to patients who were not inpatients at the time of ERCP (n=9,745).
¥
Immediate hospitalization is defined as a hospitalization that occurred within 24 hours of the index ERCP.
‡
Because length of stay is highly skewed to the right, comparisons are based on its logarithmic transform.
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Table 4
Multivariate analysis: Risk of ERCP failure
Odds Ratio 95% Confidence Interval P-value
Patient characteristics
Age 0.999 0.996 1.003 0.746
Gender, male vs. female 1.257 1.097 1.440 0.001
Race: Black vs. White 1.003 0.802 1.255 0.978
Race: Other vs. White 0.961 0.721 1.282 0.786
Race: Missing vs. White 0.897 0.712 1.131 0.355
Inpatient at ERCP 1.521 1.315 1.759 <0.001
Inpatient at ERCP: admitted one day before ERCP 0.892 0.730 1.090 0.260
Charlson Comorbidity Index, 1+ vs. 0 1.398 1.058 1.848 0.019
Gallstone Disease 1.182 1.018 1.371 0.028
Other bile duct/liver pathology 1.129 0.963 1.323 0.134
Bile duct obstruction 1.486 1.253 1.761 <0.001
Abdominal symptoms 1.040 0.901 1.201 0.589
Abnormal laboratory parameters 1.101 0.933 1.299 0.254
Acute pancreatitis 0.698 0.536 0.909 0.008
Chronic pancreatitis 0.566 0.414 0.773 0.001
Provider characteristics
Physician specialty – Gastroenterologist* - - - -
Board certification* -- - - -
Years since primary board certification 0.994 0.980 1.008 0.411
Physician volume, when < 25 0.967 0.950 0.984 <0.001
Physician volume, when 25+ 1.000 0.994 1.006 0.997
*
Physician specialty and board certification are not included in the analysis because 92% of physicians are Gastroenterologists, and 90% are board
certified
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